Antidote CME



Rheumatoid Arthritis:
Effective Management Strategies for Patient-Tailored Care

Up to 1.0 AMA PRA Category 1 Credits
Up to 1 AAFP Prescribed Credits Approved

Release Date: January 24, 2012
Expiration Date: January 24, 2013

Target Audience
This initiative has been developed for physicians, physician assistants, nurses, nurse practitioners, pharmacists, and other health care professionals who treat patients with rheumatoid arthritis.

Statement of Purpose
Rheumatoid arthritis is the most common inflammatory arthritis, thought to affect almost 1% of the adult population worldwide. RA is responsible for an estimated 250,000 hospitalizations and 9 million physician visits each year, and its economic impact is magnified by the high level of functional impairment it causes: untreated, 20 to 30 percent of persons with rheumatoid arthritis become permanently work-disabled within three years of diagnosis. Early active treatment that is tailored to meet each patient’s needs is now established as best practice and is more likely to induce remission.

This CME activity will describe the evidence-based American College of Rheumatology Classification guidelines and other evaluation tools that can facilitate early diagnosis of RA, driving early initiation of patient-tailored therapy.

Learning Objectives
Upon completion of this activity, you should be able to:

  1. Incorporate evidence-based ACR Classification guidelines and evaluation tools for the early diagnosis of RA.
  2. Recognize the importance of early initiation of DMARD therapy for patients with RA in order to improve patient outcomes.
  3. Design care plans for RA focused on patient-centered therapy.
  4. Understand the efficacy and safety of new and emerging DMARD agents for managing RA.


  • Alert signs for diagnosis
  • Evidence for the importance of early referral for initiation of treatment
  • The case for patient-tailored care
  • Case studies: Initial office visit to tailoring treatment to the patient


Stanley Cohen, MD

Clinical Professor, Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas, TX; Co- Director, Division of Rheumatology, Presbyterian Hospital, Dallas, TX; Co-Medical Director, Metroplex Clinical Research Center, Dallas, TX; Physician, Rheumatology Associates, Dallas, TX.

Louis Kuritzky, MD
Clinical Assistant Professor, Department of Community Health and Family Medicine, University of Florida, Gainesville, FL

Leonard Reeves, MD

Assistant Dean, Northwest GA Clinical Campus, Georgia Health Sciences University, Rome, GA

Michael Fleming, MD, FAAFP

Assistant Clinical Professor of Family Medicine and Comprehensive Care at LSU Health Science Center School of Medicine in Shreveport, and Assistant Clinical Professor of Family Medicine in the Department of Family and Community Medicine at Tulane University Medical School. Chief Medical Officer, Antidote Education Company & Amedisys, Inc.

R. Clark Gillett, MD
Associate Program Director, Columbus Family Medicine Residency Program, Columbus, GA

ACCME: The Georgia Academy of Family Physicians is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Georgia Academy of Family Physicians designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP: This Enduring Material activity, Rheumatoid Arthritis: Effective Management Strategies for Patient-Tailored Care, has been reviewed and is acceptable for up to 1 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins January 24, 2012. Term of approval is for one year from this date with the option of yearly renewal. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA: This program has been accredited by the American Osteopathic Association for 1 credit hours of AOA Category 2-B credit.

AAPA: AAPA accepts certificates of participation for educational activities certified for Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1 hour of Category I credit for completing this program.

Commercial Support:
This CME activity is supported by an unrestricted educational grant from Abbott Laboratories.

Method of Participation

  • Read the learning objectives and faculty disclosures.
  • Click on the link below to participate in the online activity. Answer any polling questions presented.
  • Complete the post-test and evaluation presented at the end of the activity.

A statement of credit will be issued automatically upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. You will have 3 opportunities to successfully complete the post-test.

Antidote is committed to creating, developing, and operating high-quality, relevant, and practical continuing medical education activities that are in compliance with the ACCME's policies on commercial support and disclosure. Specifically, we are dedicated to ensuring that our events are planned and implemented free of the control of commercial interests and to identifying and resolving conflicts of interest of all persons in a position to control the content of an educational activity before the educational activity is delivered to our attendees. In addition, it is our standard practice to disclose all relevant financial relationships of our speakers in writing to our attendees before the beginning of an educational activity.

Individuals in a position to control the content of this CME activity reported the following relevant financial relationships with commercial interests:

Stanley Cohen, MD
Presenting Faculty
Research Grants: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Merck, Novartis, Pfizer, Wyeth and Biogen
Consulting: Bristol-Myers Squibb, Pfizer and Biogen

Louis Kuritzky, MD
Presenting Faculty
Honoraria & Consulting: AstraZeneca, Endo, Boehringer Ingelheim, Bristol-Myers Squibb, Kowa, Eli Lilly, Forest Laboratories, GE Healthcare, Astelles, PriCare, NovoNordisk, Merck, Novartis, Ortho McNeil, Sanofi-Aventis, Takeda, Diachi Sankyo, Amylin
Honoraria Only: Abbott Laboratories

Leonard Reeves, MD
No relevant financial relationships to disclose

Michael Fleming, MD, FAAFP
Program development
No relevant financial relationships to disclose

R. Clark Gillett, MD
Content review
No relevant financial relationships to disclose

Software Requirements:
An internet browser:
Internet Explorer 6.0 or newer, Firefox or Safari
Your browser must have cookies enabled and allow pop ups.

A media player:
Windows Media Player or Adobe Flash Player

It is HIGHLY recommended that you test your computer system to ensure you have the appropriate software and settings. To test your system, click the link below and then click the "System Test" button in the upper left side of the screen. This will run a compatibility check of your computer for the web seminar listing any issues of compatibility that could cause you not to be able to participate.


Click here to view

Presented with:GAFP


Webinar Specifics

Statement of Purpose
Learning Objectives

Would you like to watch with a group?

In Partnership with the following AAFP chapters:

North Carolina
West Virginia

Tech Support
If you are having issues viewing the webinar:
1. Test your system
2. Email support at and let them know your issue. Don't forget to include your telephone number.


























































about us | current events & activities | support | news | careers | contact us | site map | privacy policy
2005-2018 © Antidote Education Company.  All Rights Reserved